Sylvie Lachance

7PUBLICATIONS
57CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 09, 2026
Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

|Apr 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group.

Marion Larue, Florent Malard, Ahmed S Alaskar

|Mar 26, 2025
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience.

Eva Laverdure, Luigina Mollica, Imran Ahmad

|Nov 26, 2024
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.

Richard LeBlanc, Stéphanie Thiant, Rafik Terra

|Mar 27, 2024
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.

Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic

Pageof 2

Frequent Collaborators

4 joint publications

Imran Ahmad

2 joint publications

Richard LeBlanc

2 joint publications

Igor Novitzky-Basso

2 joint publications

Guy Sauvageau